{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:58:24Z","timestamp":1777892304711,"version":"3.51.4"},"reference-count":62,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Royal College of Physicians of Edinburgh"],"published-print":{"date-parts":[[2013,3]]},"abstract":"<jats:p>Neurological diseases are a major cause of morbidity and mortality in pregnancy. The management of multiple sclerosis, epilepsy, myasthenia gravis, certain neuropathies and headache in pregnancy is described; the potentially life-threatening conditions of stroke and eclampsia are also discussed. Management of most neurological conditions is similar to outside of pregnancy, but special consideration should be given to delivery plans and the safety of medications antenatally and during breastfeeding. Pre-pregnancy counselling, regular review and effective communication among a multi-disciplinary team are key to optimising management and outcomes.<\/jats:p>","DOI":"10.4997\/jrcpe.2013.112","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T04:35:30Z","timestamp":1363926930000},"page":"49-58","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Neurological diseases in pregnancy"],"prefix":"10.1177","volume":"43","author":[{"given":"D","family":"Kevat","sequence":"first","affiliation":[{"name":"Honorary Specialist Registrar, Oxford University Hospitals NHS Trust, Oxford, UK and PhD candidate, School of Public Health, Monash University, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Mackillo","sequence":"additional","affiliation":[{"name":"Consultant Obstetric Physician, Oxford University Hospitals NHS Trust, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2013,3]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"crossref","unstructured":"1 Kametas NA McAuliffe F Krampl E Maternal cardiac function in twin pregnancy. Obstet Gynecol 2003; 102:806\u201315. http:\/\/dx.doi.org\/10.1016\/S0029-7844(03)00807-X","DOI":"10.1097\/00006250-200310000-00024"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","unstructured":"2 Duvekot JJ Peeters LL. Maternal cardiovascular hemodynamic adaptation to pregnancy. Obstet Gynecol Surv 1994; 49:S1\u201314. http:\/\/dx.doi.org\/10.1097\/00006254-199412011-00001","DOI":"10.1097\/00006254-199412011-00001"},{"key":"e_1_2_1_4_1","first-page":"409","volume":"114","author":"Brenner B.","year":"2004","unstructured":"3 Brenner B. Haemostatic changes in pregnancy. Thromb Res 2004; 114:409\u201314. http:\/\/dx.doi.org\/10.1016\/j.thromres.2004.08.004","journal-title":"Haemostatic changes in pregnancy"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","unstructured":"4 Saraste M Vaisanen S Alanen A Clinical and immunologic evaluation of women with multiple sclerosis during and after pregnancy. Gend Med 2007; 4:45\u201355. http:\/\/dx.doi.org\/10.1016\/S1550-8579(07)80008-8","DOI":"10.1016\/S1550-8579(07)80008-8"},{"key":"e_1_2_1_6_1","doi-asserted-by":"crossref","unstructured":"5 Anderson GD. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 2005; 44:989\u2013 1008. http:\/\/dx.doi.org\/10.2165\/00003088-200544100-00001","DOI":"10.2165\/00003088-200544100-00001"},{"key":"e_1_2_1_7_1","first-page":"288","volume":"61","author":"Ascherio A","year":"2007","unstructured":"6 Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007; 61:288\u201399. http:\/\/dx.doi.org\/10.1002\/ana.21117","journal-title":"Environmental risk factors for multiple sclerosis. Part I: the role of infection"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","unstructured":"7 Pugliatti M Rosati G Carton H The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006; 13:700\u201322. http:\/\/dx.doi.org\/10.1111\/j.1468-1331.2006.01342.x","DOI":"10.1111\/j.1468-1331.2006.01342.x"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","unstructured":"8 Vukusic S Hutchinson M Hours M Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 2004; 127:1353\u201360. http:\/\/dx.doi.org\/10.1093\/brain\/awh152","DOI":"10.1093\/brain\/awh152"},{"key":"e_1_2_1_10_1","doi-asserted-by":"crossref","unstructured":"9 Salminen HJ Leggett H Boggild M. Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes. J Neurol 2010; 257:2020\u20133. http:\/\/dx.doi.org\/10.1007\/s00415-010-5652-y","DOI":"10.1007\/s00415-010-5652-y"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","unstructured":"10 Lu E Wang BW Guimond C Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review. Neurology 2012; 79:1130\u20135. http:\/\/dx.doi.org\/10.1212\/WNL.0b013e3182698c64","DOI":"10.1212\/WNL.0b013e3182698c64"},{"key":"e_1_2_1_12_1","first-page":"900","volume":"13","author":"Haas J","year":"2007","unstructured":"11 Haas J, Hommes OR. A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis. Mult Scler 2007; 13:900\u20138. http:\/\/dx.doi.org\/10.1177\/1352458506075654","journal-title":"A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","unstructured":"12 Vukusic S Ionescu I El-Etr M The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART\u2019MUS) trial: rationale objectives and state of advancement. J Neurol Sci 2009; 286:114\u20138. http:\/\/dx.doi.org\/10.1016\/j.jns.2009.08.056","DOI":"10.1016\/j.jns.2009.08.056"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","unstructured":"13 MacDonald BK Cockerell OC Sander JW The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000; 123:665\u201376. http:\/\/dx.doi.org\/10.1093\/brain\/123.4.665","DOI":"10.1093\/brain\/123.4.665"},{"key":"e_1_2_1_15_1","first-page":"82","volume":"34","author":"Plauche WC.","year":"1991","unstructured":"14 Plauche WC. Myasthenia gravis in mothers and their newborns. Clin Obstet Gynecol 1991; 34:82\u201399. http:\/\/dx.doi.org\/10.1097\/00003081-199103000-00012","journal-title":"Myasthenia gravis in mothers and their newborns"},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","unstructured":"15 Hoff JM Daltveit AK Gilhus NE. Myasthenia gravis: consequences for pregnancy delivery and the newborn. Neurology 2003; 61:1362\u2013 6. http:\/\/dx.doi.org\/10.1212\/01.WNL.0000082725.21444.EC","DOI":"10.1212\/01.WNL.0000082725.21444.EC"},{"key":"e_1_2_1_17_1","first-page":"559","volume":"11","author":"Hoff JM","year":"2004","unstructured":"16 Hoff JM, Daltveit AK, Gilhus NE. Asymptomatic myasthenia gravis influences pregnancy and birth. Eur J Neurol 2004; 11:559\u201362. http:\/\/dx.doi.org\/10.1111\/j.1468-1331.2004.00900.x","journal-title":"Asymptomatic myasthenia gravis influences pregnancy and birth"},{"key":"e_1_2_1_18_1","first-page":"708","volume":"13","author":"Bashuk RG","year":"1990","unstructured":"17 Bashuk RG, Krendel DA. Myasthenia gravis presenting as weakness after magnesium administration. Muscle Nerve 1990; 13:708\u201312. http:\/\/dx.doi.org\/10.1002\/mus.880130808","journal-title":"Myasthenia gravis presenting as weakness after magnesium administration"},{"key":"e_1_2_1_19_1","first-page":"819","article-title":"Respiratory arrest during therapy for premature labor in a patient with myasthenia gravis","volume":"64","author":"Catanzarite VA","year":"1984","unstructured":"18 Catanzarite VA, McHargue AM, Sandberg EC Respiratory arrest during therapy for premature labor in a patient with myasthenia gravis. Obstet Gynecol 1984; 64:819\u201322.","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","unstructured":"19 Ahmad S. Myasthenia gravis unmasked by ergonovine. Am Heart J 1991; 121:1851. http:\/\/dx.doi.org\/10.1016\/0002-8703(91)90070-X","DOI":"10.1016\/0002-8703(91)90070-X"},{"key":"e_1_2_1_21_1","first-page":"38","volume":"14","author":"Hoff JM","year":"2007","unstructured":"20 Hoff JM, Daltveit AK, Gilhus NE. Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. Eur J Neurol 2007; 14:38\u201343. http:\/\/dx.doi.org\/10.1111\/j.1468-1331.2006.01538.x","journal-title":"Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care"},{"key":"e_1_2_1_22_1","doi-asserted-by":"crossref","unstructured":"21 Gambling DR Douglas MJ McKay RSF. Obstetric anesthesia and uncommon disorders. Cambridge: Cambridge University Press; 2008. http:\/\/dx.doi.org\/10.1017\/CBO9780511544552","DOI":"10.1017\/CBO9780511544552"},{"key":"e_1_2_1_23_1","first-page":"83","volume":"24","author":"Dillon FX.","year":"2004","unstructured":"22 Dillon FX. Anesthesia issues in the perioperative management of myasthenia gravis. Semin Neurol 2004; 24:83\u201394. http:\/\/dx.doi.org\/10.1055\/s-2004-829587","journal-title":"Anesthesia issues in the perioperative management of myasthenia gravis"},{"key":"e_1_2_1_24_1","doi-asserted-by":"crossref","unstructured":"23 Rasmussen BK Jensen R Schroll M Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol 1991; 44:1147\u201357. http:\/\/dx.doi.org\/10.1016\/0895-4356(91)90147-2","DOI":"10.1016\/0895-4356(91)90147-2"},{"key":"e_1_2_1_25_1","doi-asserted-by":"crossref","unstructured":"24 Scher AI Terwindt GM Picavet HS Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005; 64:614\u201320. http:\/\/dx.doi.org\/10.1212\/01.WNL.0000151857.43225.49","DOI":"10.1212\/01.WNL.0000151857.43225.49"},{"key":"e_1_2_1_26_1","doi-asserted-by":"crossref","unstructured":"25 Facchinetti F Allais G Nappi RE Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia 2009; 29:286\u201392. http:\/\/dx.doi.org\/10.1111\/j.1468-2982.2008.01704.x","DOI":"10.1111\/j.1468-2982.2008.01704.x"},{"key":"e_1_2_1_27_1","first-page":"245","volume":"25","author":"Somerville B.","year":"1975","unstructured":"26 Somerville B. Estrogen-withdrawal migraine II. Attempted prophylaxis by continuous estradiol administration. Neurology 1975; 25:245\u201350. http:\/\/dx.doi.org\/10.1212\/WNL.25.3.245","journal-title":"Estrogen-withdrawal migraine II. Attempted prophylaxis by continuous estradiol administration"},{"key":"e_1_2_1_28_1","first-page":"355","volume":"22","author":"Somerville BW.","year":"1972","unstructured":"27 Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972; 22:355\u201365. http:\/\/dx.doi.org\/10.1212\/WNL.22.4.355","journal-title":"The role of estradiol withdrawal in the etiology of menstrual migraine"},{"key":"e_1_2_1_29_1","doi-asserted-by":"crossref","unstructured":"28 Ertresvag JM Zwart JA Helde G Headache and transient focal neurological symptoms during pregnancy a prospective cohort. Acta Neurol Scand 2005; 111:233\u20137. http:\/\/dx.doi.org\/10.1111\/j.1600-0404.2005.00350.x","DOI":"10.1111\/j.1600-0404.2005.00350.x"},{"key":"e_1_2_1_30_1","doi-asserted-by":"crossref","unstructured":"29 Cripe SM Frederick IO Qiu C Risk of preterm delivery and hypertensive disorders of pregnancy in relation to maternal co-morbid mood and migraine disorders during pregnancy. Paediatr Perinat Epidemiol 2011; 25:116\u201323. http:\/\/dx.doi.org\/10.1111\/j.1365-3016.2010.01182.x","DOI":"10.1111\/j.1365-3016.2010.01182.x"},{"key":"e_1_2_1_31_1","doi-asserted-by":"crossref","unstructured":"30 James AH Bushnell CD Jamison MG Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005; 106:509\u201316. http:\/\/dx.doi.org\/10.1097\/01.AOG.0000172428.78411.b0","DOI":"10.1097\/01.AOG.0000172428.78411.b0"},{"key":"e_1_2_1_32_1","doi-asserted-by":"crossref","unstructured":"31 Sztajzel R Genoud D Roth S Patent foramen ovale a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002; 13:102\u20136. http:\/\/dx.doi.org\/10.1159\/000047758","DOI":"10.1159\/000047758"},{"key":"e_1_2_1_33_1","first-page":"65","volume":"53","author":"Rasmussen BK.","year":"1993","unstructured":"32 Rasmussen BK. Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle. Pain 1993; 53:65\u201372. http:\/\/dx.doi.org\/10.1016\/0304-3959(93)90057-V","journal-title":"Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle"},{"key":"e_1_2_1_34_1","doi-asserted-by":"crossref","unstructured":"33 Nestoriuc Y Rief W Martin A. Meta-analysis of biofeedback for tension-type headache: efficacy specificity and treatment moderators. J Consult Clin Psychol 2008; 76:379\u201396. http:\/\/dx.doi.org\/10.1037\/0022-006X.76.3.379","DOI":"10.1037\/0022-006X.76.3.379"},{"key":"e_1_2_1_35_1","doi-asserted-by":"crossref","unstructured":"34 Linde K Allais G Brinkhaus B Acupuncture for tension-type headache. Cochrane Database Syst Rev 2009; 1:CD007587.","DOI":"10.1002\/14651858.CD007587"},{"key":"e_1_2_1_36_1","doi-asserted-by":"crossref","unstructured":"35 Linde K Allais G Brinkhaus B Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev 2009; 1:CD001218.","DOI":"10.1002\/14651858.CD001218.pub2"},{"key":"e_1_2_1_37_1","doi-asserted-by":"crossref","unstructured":"36 Olesen C Steffensen FH Sorensen HT Pregnancy outcome following prescription for sumatriptan. Headache 2000; 40:20\u20134. http:\/\/dx.doi.org\/10.1046\/j.1526-4610.2000.00003.x","DOI":"10.1046\/j.1526-4610.2000.00003.x"},{"key":"e_1_2_1_38_1","doi-asserted-by":"crossref","unstructured":"37 Holland S Silberstein SD Freitag F Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2012; 78:1346\u201353. http:\/\/dx.doi.org\/10.1212\/WNL.0b013e3182535d0c","DOI":"10.1212\/WNL.0b013e3182535d0c"},{"key":"e_1_2_1_39_1","doi-asserted-by":"crossref","unstructured":"38EURAP Study Group. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology 2006; 66:354\u201360. http:\/\/dx.doi.org\/10.1212\/01.wnl.0000195888.51845.80","DOI":"10.1212\/01.wnl.0000195888.51845.80"},{"key":"e_1_2_1_40_1","doi-asserted-by":"crossref","unstructured":"39 Cantwell R Clutton-Brock T Cooper G Saving mothers\u2019 lives: reviewing maternal deaths to make motherhood safer: 2006\u20132008. The eighth report of the confidential enquiries into maternal deaths in the United Kingdom. BJOG 2011; 118:1\u2013203. http:\/\/dx.doi.org\/10.1111\/j.1471-0528.2010.02847.x","DOI":"10.1111\/j.1471-0528.2010.02847.x"},{"key":"e_1_2_1_41_1","unstructured":"40 Bardy A. Seizure frequency in epileptic women during pregnancy and the pueperium: results of the prospective Helskinki study. In: Hanz D Bossi L Dam M et al editors. Epilepsy pregnancy and the child. New York: Raven Press; 1982. p.27\u201337."},{"key":"e_1_2_1_42_1","unstructured":"41 Bassi V. Epilepsy. In: Hainline B Devinsky O. Neurological complications of pregnancy. Philadelphia: Lippincott Williams &Wilkins; 2002."},{"key":"e_1_2_1_43_1","doi-asserted-by":"crossref","unstructured":"42 Tomson T Battino D. Teratogenic effects of antiepileptic drugs. Lancet Neurol 2012; 11:803\u201313. http:\/\/dx.doi.org\/10.1016\/S1474- 4422(12)70103-5","DOI":"10.1016\/S1474-4422(12)70103-5"},{"key":"e_1_2_1_44_1","doi-asserted-by":"crossref","unstructured":"43 Sabers A. Algorithm for lamotrigine dose adjustment before during and after pregnancy. Acta Neurol Scand 2012; 126:e1\u20134. http:\/\/dx.doi.org\/10.1111\/j.1600-0404.2011.01627.x","DOI":"10.1111\/j.1600-0404.2011.01627.x"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17987-2"},{"key":"e_1_2_1_46_1","unstructured":"45 Kaplan P. Neurological aspects of eclampsia In: Hainline B Devinsky O. Neurological complications of pregnancy. Philadelphia: Lippincott Williams &Wilkins; 2002."},{"key":"e_1_2_1_47_1","volume-title":"Handbook of obstetric medicine","author":"Nelson-Piercy C.","year":"2006","unstructured":"46 Nelson-Piercy C. Handbook of obstetric medicine. London: Informa HealthCare; 2006."},{"key":"e_1_2_1_48_1","doi-asserted-by":"crossref","unstructured":"47 Liang CC Chang SD Lai SL Stroke complicating pregnancy and the puerperium. Eur J Neurol 2006; 13:1256\u201360. http:\/\/dx.doi.org\/10.1111\/j.1468-1331.2006.01490.x","DOI":"10.1111\/j.1468-1331.2006.01490.x"},{"key":"e_1_2_1_49_1","doi-asserted-by":"crossref","unstructured":"48 Wiebers DO The incidence of stroke among pregnant women in Rochester Whisnant JP. Minn 1955 through 1979. JAMA 1985; 254:3055\u20137. http:\/\/dx.doi.org\/10.1001\/jama.1985.03360210071032","DOI":"10.1001\/jama.1985.03360210071032"},{"key":"e_1_2_1_50_1","doi-asserted-by":"crossref","unstructured":"49 Sharshar T Lamy C Incidence Mas JL. of causes strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de\u00a0France. Stroke 1995; 26:930\u20136. http:\/\/dx.doi.org\/10.1161\/01.STR.26.6.930","DOI":"10.1161\/01.STR.26.6.930"},{"key":"e_1_2_1_51_1","doi-asserted-by":"crossref","unstructured":"50 Scott CA Bewley S Rudd A Incidence risk factors management and outcomes of stroke in pregnancy. Obstet Gynecol 2012; 120:318\u201324. http:\/\/dx.doi.org\/10.1097\/AOG.0b013e31825f287c","DOI":"10.1097\/AOG.0b013e31825f287c"},{"key":"e_1_2_1_52_1","doi-asserted-by":"crossref","unstructured":"51 Kuklina EV Tong X Bansil P Trends in pregnancy hospitalizations that included a stroke in the United States from 1994 to 2007: reasons for concern? Stroke 2011; 42:2564\u201370. http:\/\/dx.doi.org\/10.1161\/STROKEAHA.110.610592","DOI":"10.1161\/STROKEAHA.110.610592"},{"key":"e_1_2_1_53_1","doi-asserted-by":"crossref","unstructured":"52 Rothwell PM Coull AJ Giles MF Change in stroke incidence mortality case-fatality severity and risk factors in Oxfordshire UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004; 363:1925\u201333. http:\/\/dx.doi.org\/10.1016\/S0140-6736(04)16405-2","DOI":"10.1016\/S0140-6736(04)16405-2"},{"key":"e_1_2_1_54_1","doi-asserted-by":"crossref","unstructured":"53 Ogilvy CS Stieg PE Awad I Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council American Stroke Association. Circulation 2001; 103:2644\u201357. http:\/\/dx.doi.org\/10.1161\/01.CIR.103.21.2644","DOI":"10.1161\/01.CIR.103.21.2644"},{"key":"e_1_2_1_55_1","doi-asserted-by":"crossref","unstructured":"54 Gross BA Du R. Hemorrhage from arteriovenous malformations during pregnancy. Neurosurgery 2012; 71:349\u201355; discussion 55\u20136. http:\/\/dx.doi.org\/10.1227\/NEU.0b013e318256c34b","DOI":"10.1227\/NEU.0b013e318256c34b"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0761"},{"key":"e_1_2_1_57_1","doi-asserted-by":"crossref","unstructured":"56 Lanska DJ Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000; 31:1274\u2013 82. http:\/\/dx.doi.org\/10.1161\/01.STR.31.6.1274","DOI":"10.1161\/01.STR.31.6.1274"},{"key":"e_1_2_1_58_1","doi-asserted-by":"crossref","unstructured":"57 Nelson-Piercy C. Handbook of obstetric medicine. 3rd ed. London: Informa Healthcare; 2010. p. 193.","DOI":"10.3109\/9781841847382"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21910"},{"key":"e_1_2_1_60_1","volume-title":"Neurology of pregnancy","author":"Donaldson J.","year":"1989","unstructured":"59 Donaldson J. Neurology of pregnancy. Philadelphia: WB Saunders; 1989."},{"key":"e_1_2_1_61_1","doi-asserted-by":"crossref","unstructured":"60 Katz A Sergienko R Dior U Bell's palsy during pregnancy: is it associated with adverse perinatal outcome? Laryngoscope 2011; 121:1935\u20138;","DOI":"10.1002\/lary.21860"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1177\/000348947508400402"},{"key":"e_1_2_1_63_1","doi-asserted-by":"crossref","unstructured":"62 Salinas RA Alvarez G Daly F Corticosteroids for Bell\u2019s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2010; 3:CD001942.","DOI":"10.1002\/14651858.CD001942.pub4"}],"container-title":["Journal of the Royal College of Physicians of Edinburgh"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4997\/JRCPE.2013.112","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4997\/JRCPE.2013.112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:26:17Z","timestamp":1777616777000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.4997\/JRCPE.2013.112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.4997\/JRCPE.2013.112"],"URL":"https:\/\/doi.org\/10.4997\/jrcpe.2013.112","relation":{},"ISSN":["1478-2715","2042-8189"],"issn-type":[{"value":"1478-2715","type":"print"},{"value":"2042-8189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}